World's Best Scientists 2026 revealed!
Giorgio Inghirami

Giorgio Inghirami

D-Index & Metrics

Medicine

D-Index
104
Citations
37537
World Ranking
7089
National Ranking
3727

Giorgio Inghirami publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Giorgio Inghirami sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 504 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Giorgio Inghirami D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Giorgio Inghirami sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Giorgio Inghirami is affiliated with Cornell University in the United States. Their research spans multiple fields within Medicine and Biochemistry, Genetics, and Molecular Biology, with particular emphasis on Molecular Biology, Pathology and Forensic Medicine, Oncology, Immunology, and Genetics.

The main research topics covered in their publications include:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • T-cell and Retrovirus Studies
  • Chronic Lymphocytic Leukemia Research
  • Immune Cell Function and Interaction
  • Cancer Genomics and Diagnostics
  • Ubiquitin and proteasome pathways

Notable recent papers authored by Inghirami include:

  • Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring, 2020, Nature Medicine
  • Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures, 2021, Cancer Discovery
  • Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia, 2020, Nature Genetics
  • Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma, 2020, Cancer Discovery
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas, 2021, Blood

Inghirami frequently publishes in the following venues:

  • Blood
  • Cancer Research
  • Hematological Oncology
  • Blood Advances
  • bioRxiv (Cold Spring Harbor Laboratory)

Their collaborative network includes frequent co-authors such as Olivier Elemento, Leandro Cerchietti, Andrew L. Feldman, Jia Ruan, and Wing C. Chan, reflecting sustained partnerships on various research projects.

Best Publications

  • DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

    Claire Vanpouille-Box;Amandine Alard;Amandine Alard;Molykutty J. Aryankalayil;Yasmeen Sarfraz

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells

    Ulf Klein;Yuhai Tu;Gustavo A. Stolovitzky;Michela Mattioli

  • p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

    Gianluca Gaidano;Paola Ballerini;Jerry Z. Gong;Giorgio Inghirami

  • The anaplastic lymphoma kinase in the pathogenesis of cancer.

    Roberto Chiarle;Claudia Voena;Chiara Ambrogio;Roberto Piva;Roberto Piva

  • Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.

    Donald Kufe;Giorgio Inghirami;Miyako Abe;Daniel Hayes

  • Stromal contribution to the colorectal cancer transcriptome

    Claudio Isella;Andrea Terrasi;Sara Erika Bellomo;Consalvo Petti

  • Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset

    Paolo Casali;Samuele .E Burastero;Minoru Nakamura;Giorgio Inghirami

  • Genetics of Follicular Lymphoma Transformation

    Laura Pasqualucci;Hossein Khiabanian;Marco Fangazio;Mansi Vasishtha

  • β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis

    Wenjun Guo;Yuliya Pylayeva;Yuliya Pylayeva;Angela Pepe;Toshiaki Yoshioka

  • In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences

    Ethel Cesarman;Patrick S. Moore;Pulirarthy H. Rao;Giorgio Inghirami

  • Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

    Roberto Chiarle;William J Simmons;Honjying Cai;Girish Dhall

  • Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.

    Ramona Crescenzo;Ramona Crescenzo;Francesco Abate;Francesco Abate;Francesco Abate;Elena Lasorsa;Fabrizio Tabbo;Fabrizio Tabbo

  • Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

    Alberto Zamo;Roberto Chiarle;Roberto Piva;Jennifer Howes

  • The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development

    Davide Rossi;Vladimir Trifonov;Marco Fangazio;Alessio Bruscaggin

  • Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus.

    Daniel M. Knowles;Giorgio Inghirami;Angela Ubriaco;Riccardo Dalla-Favera

  • A targeted mutational landscape of angioimmunoblastic T-cell lymphoma

    Oreofe Odejide;Oliver Weigert;Oliver Weigert;Andrew A. Lane;Dan Toscano

  • Role of the F-box protein Skp2 in lymphomagenesis.

    Esther Latres;Roberto Chiarle;Brenda A. Schulman;Nikola P. Pavletich

  • Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma.

    Milayna Subar;Antonino Neri;Giorgio Inghirami;Daniel M. Knowles

  • A Targeted Mutational Landscape of Angioimmunoblastic T-Cell Lymphoma: Association Between Advanced Age and Mutations in TET2 and DNMT3A

    Oliver Weigert;Nadja Kopp;Sudha Bolla;Oreofe Odejide

Frequent Co-Authors

Roberto Chiarle
Roberto Chiarle Harvard University
Francesco Bertoni
Francesco Bertoni Institute of Oncology Research
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Daniel M. Knowles
Daniel M. Knowles Cornell University
Stefano Pileri
Stefano Pileri European Institute of Oncology
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Antonino Neri
Antonino Neri University of Milan
Davide Rossi
Davide Rossi European Society for Medical Oncology
Emanuele Zucca
Emanuele Zucca Universita della Svizzera Italiana
Olivier Elemento
Olivier Elemento Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but want alternatives to the traditional MD path, there are several online healthcare degree options to consider. These programs can offer flexibility, shorter durations, and unique entry requirements—especially valuable for career changers or those balancing work and study.

For individuals without a nursing background, direct entry msn programs for non nurses online provide an accelerated route into advanced nursing roles. Those looking for accessible entry points might consider direct admit nursing programs, which often feature fewer competitive barriers and more streamlined admissions.

Students interested in healthcare administration can explore medical coding and billing classes online with financial aid. These programs open doors to in-demand medical office careers without the lengthy commitment of clinical training.

Finally, licensed practical nurses seeking career progression can benefit from lpn to rn programs without teas test, which eliminate standardized testing barriers and streamline advancement. Exploring these diverse pathways can help you find the right online degree and career in healthcare.

Best Scientists Citing Giorgio Inghirami

Trending Scientists

Recently Published Articles